TRDA, a technology-based company, is scheduled to report its quarterly earnings on May 11. Analysts are expecting a significant rise in earnings, with estimates pointing to a 20% increase, bringing earnings per share (EPS) to -63 cents. The last earnings report on December 31 showed better-than-expected results, with earnings per share of -79 cents, beating the estimate of -83 cents. In this article, we will dive into TRDA's financial ratios and technical indicators to analyze its potential performance after the earnings release.
Sign up for one of these top-performing robots today and start earning more profits in no time!
Key Financial Ratios
Price-to-Book (P/B) Ratio: TRDA's P/B ratio of 1.903 is in line with the industry mean of 23.555, suggesting that the stock is fairly valued relative to its peers.
Price-to-Earnings (P/E) Ratio: The company's P/E ratio of 0.000 is within average values for comparable stocks (124.876), indicating that it is not overpriced based on its earnings.
Projected Growth (PEG Ratio): TRDA's PEG ratio of 0.000 is also within normal values, averaging 3.848, suggesting that the stock's growth prospects are in line with industry standards.
Dividend Yield: The company's dividend yield of 0.000 is around the average of 0.029 among similar stocks, which means that investors can expect a reasonable return on their investment.
Price-to-Sales (P/S) Ratio: TRDA's P/S ratio of 0.000 is also within normal values, averaging 317.511, which implies that the stock is not overvalued based on its sales.
Market Capitalization
With 39.57K shares outstanding, TRDA's current market capitalization sits at $384.64 million. This figure indicates that the company has a reasonable market size, and it has the potential to generate higher revenues in the future.
Technical Analysis
TRDA's 10-day Relative Strength Index (RSI) Indicator recently moved out of the overbought zone on April 18, 2023. This development could signal a shift from an upward trend to a downward trend. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor analyzed 6 instances where the RSI indicator left the overbought zone, and in all cases, the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Although TRDA's financial ratios are within average values, the recent RSI indicator movement suggests that the stock might experience a downward trend in the short term. Investors should closely monitor the company's earnings release on May 11 and consider their investment strategy accordingly. While the company has demonstrated growth in its last earnings report, the technical indicators point towards potential challenges in the near future.
TRDA saw its Momentum Indicator move above the 0 level on February 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for TRDA just turned positive on February 20, 2026. Looking at past instances where TRDA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
TRDA moved above its 50-day moving average on February 10, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TRDA crossed bullishly above the 50-day moving average on February 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRDA advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for TRDA moved out of overbought territory on February 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where TRDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
TRDA broke above its upper Bollinger Band on February 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.564) is normal, around the industry mean (29.921). P/E Ratio (10.259) is within average values for comparable stocks, (46.177). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.828). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (20.367) is also within normal values, averaging (315.120).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology